Opaleye Management Inc. - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 57 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,342,000
+8.7%
240,000
-8.9%
0.42%
+59.2%
Q4 2021$1,235,000
-56.1%
263,400
-42.2%
0.26%
-50.2%
Q3 2021$2,816,000
-34.0%
455,600
-29.6%
0.53%
-25.7%
Q2 2021$4,264,000
-30.2%
647,000
-22.5%
0.71%
-21.2%
Q1 2021$6,112,000
+1702.9%
835,000
+1320.1%
0.90%
+1940.9%
Q4 2020$339,00058,8000.04%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
PATHWAY CAPITAL MANAGEMENT, LP 245,606$3,671,8106.55%
AIGH Capital Management LLC 695,358$10,395,6023.42%
BARDIN HILL MANAGEMENT PARTNERS LP 638,360$9,5442.08%
Kellner Capital, LLC 100,016$1,4951.74%
NEXPOINT ASSET MANAGEMENT, L.P. 1,464,807$21,898,8651.70%
Worth Venture Partners, LLC 170,925$2,555,3291.51%
Birchview Capital, LP 100,000$1,4951.06%
BCK CAPITAL MANAGEMENT LP 68,000$1,016,6001.05%
WATER ISLAND CAPITAL LLC 698,915$10,4490.89%
EHP Funds Inc. 292,043$4,3660.82%
View complete list of AVEO PHARMACEUTICALS INC shareholders